James C. Fredenburgh

4.4k total citations · 2 hit papers
79 papers, 3.4k citations indexed

About

James C. Fredenburgh is a scholar working on Hematology, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, James C. Fredenburgh has authored 79 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Hematology, 21 papers in Cardiology and Cardiovascular Medicine and 20 papers in Pulmonary and Respiratory Medicine. Recurrent topics in James C. Fredenburgh's work include Blood Coagulation and Thrombosis Mechanisms (55 papers), Blood properties and coagulation (20 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (19 papers). James C. Fredenburgh is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (55 papers), Blood properties and coagulation (20 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (19 papers). James C. Fredenburgh collaborates with scholars based in Canada, United States and Australia. James C. Fredenburgh's co-authors include Jeffrey I. Weitz, Alan R. Stafford, John W. Eikelboom, Iqbal Jaffer, J. Hirsh, Beverly A. Leslie, Michael E. Nesheim, Jonathan W. Yau, Trang Vu and Peng Liao and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

James C. Fredenburgh

76 papers receiving 3.3k citations

Hit Papers

Medical device‐induced thrombosis: what causes it and how... 2015 2026 2018 2022 2015 2017 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James C. Fredenburgh Canada 34 1.4k 757 654 575 565 79 3.4k
Nicola J. Mutch United Kingdom 28 1.6k 1.1× 416 0.5× 892 1.4× 1.0k 1.8× 360 0.6× 67 3.6k
Jolyon Jesty United States 34 1.5k 1.1× 799 1.1× 612 0.9× 489 0.9× 517 0.9× 83 3.2k
Thomas Orfeo United States 29 1.1k 0.8× 294 0.4× 446 0.7× 347 0.6× 839 1.5× 73 3.3k
Theo Lindhout Netherlands 29 1.7k 1.2× 540 0.7× 518 0.8× 339 0.6× 471 0.8× 68 2.8k
William P. Fay United States 39 1.8k 1.3× 1.1k 1.4× 999 1.5× 424 0.7× 1.2k 2.1× 93 5.5k
M. Anna Kowalska United States 37 2.0k 1.4× 417 0.6× 453 0.7× 434 0.8× 1.3k 2.4× 113 4.9k
Duncan S. Pepper United Kingdom 37 1.5k 1.1× 546 0.7× 705 1.1× 285 0.5× 980 1.7× 128 4.1k
Shirley K. Wrobleski United States 30 1.5k 1.1× 785 1.0× 553 0.8× 230 0.4× 942 1.7× 58 4.4k
G. Müller‐Berghaus Germany 31 1.8k 1.3× 871 1.2× 821 1.3× 292 0.5× 626 1.1× 111 4.7k
Frederick A. Ofosu Canada 40 2.8k 1.9× 1.4k 1.8× 619 0.9× 464 0.8× 663 1.2× 162 5.2k

Countries citing papers authored by James C. Fredenburgh

Since Specialization
Citations

This map shows the geographic impact of James C. Fredenburgh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James C. Fredenburgh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James C. Fredenburgh more than expected).

Fields of papers citing papers by James C. Fredenburgh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James C. Fredenburgh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James C. Fredenburgh. The network helps show where James C. Fredenburgh may publish in the future.

Co-authorship network of co-authors of James C. Fredenburgh

This figure shows the co-authorship network connecting the top 25 collaborators of James C. Fredenburgh. A scholar is included among the top collaborators of James C. Fredenburgh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James C. Fredenburgh. James C. Fredenburgh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fredenburgh, James C., et al.. (2024). Histidine-Rich Glycoprotein Modulates the Toxic Effects of High-Dose Polyphosphate in Mice. Arteriosclerosis Thrombosis and Vascular Biology. 44(7). 1658–1670.
2.
Fredenburgh, James C., et al.. (2023). Allosteric modulation of exosite 1 attenuates polyphosphate-catalyzed activation of factor XI by thrombin. Journal of Thrombosis and Haemostasis. 21(1). 83–93. 3 indexed citations
3.
Liao, Peng, et al.. (2023). Histidine-rich glycoprotein attenuates catheter thrombosis. Blood Advances. 7(18). 5651–5660. 7 indexed citations
4.
Fredenburgh, James C. & Jeffrey I. Weitz. (2023). News at XI: moving beyond factor Xa inhibitors. Journal of Thrombosis and Haemostasis. 21(7). 1692–1702. 27 indexed citations
5.
Fredenburgh, James C., et al.. (2021). Identification of the histidine‐rich glycoprotein domains responsible for contact pathway inhibition. Journal of Thrombosis and Haemostasis. 20(4). 821–832. 6 indexed citations
6.
Zhou, Ji, et al.. (2021). Polyphosphate-induced thrombosis in mice is factor XII dependent and is attenuated by histidine-rich glycoprotein. Blood Advances. 5(18). 3540–3551. 19 indexed citations
7.
Fredenburgh, James C. & Jeffrey I. Weitz. (2020). New anticoagulants: Moving beyond the direct oral anticoagulants. Journal of Thrombosis and Haemostasis. 19(1). 20–29. 48 indexed citations
8.
Jaffer, Iqbal, James C. Fredenburgh, Alan R. Stafford, Richard Whitlock, & Jeffrey I. Weitz. (2019). Rivaroxaban and Dabigatran for Suppression of Mechanical Heart Valve–Induced Thrombin Generation. The Annals of Thoracic Surgery. 110(2). 582–590. 12 indexed citations
9.
Jaffer, Iqbal, James C. Fredenburgh, J. Hirsh, & Jeffrey I. Weitz. (2015). Medical device‐induced thrombosis: what causes it and how can we prevent it?. Journal of Thrombosis and Haemostasis. 13. S72–S81. 424 indexed citations breakdown →
10.
Kim, Paul Y., Trang Vu, Beverly A. Leslie, et al.. (2014). Reduced Plasminogen Binding and Delayed Activation Render γ′-Fibrin More Resistant to Lysis than γA-Fibrin. Journal of Biological Chemistry. 289(40). 27494–27503. 8 indexed citations
11.
Yau, Jonathan W., Alan R. Stafford, Peng Liao, et al.. (2012). Corn trypsin inhibitor coating attenuates the prothrombotic properties of catheters in vitro and in vivo. Acta Biomaterialia. 8(11). 4092–4100. 66 indexed citations
12.
Yau, Jonathan W., Alan R. Stafford, Peng Liao, et al.. (2011). Mechanism of catheter thrombosis: comparison of the antithrombotic activities of fondaparinux, enoxaparin, and heparin in vitro and in vivo. Blood. 118(25). 6667–6674. 84 indexed citations
13.
Kim, Paul Y., et al.. (2011). A High Affinity Interaction of Plasminogen with Fibrin Is Not Essential for Efficient Activation by Tissue-type Plasminogen Activator. Journal of Biological Chemistry. 287(7). 4652–4661. 35 indexed citations
14.
Vu, Trang, Alan R. Stafford, Beverly A. Leslie, et al.. (2011). Histidine-rich Glycoprotein Binds Fibrin(ogen) with High Affinity and Competes with Thrombin for Binding to the γ′-Chain. Journal of Biological Chemistry. 286(35). 30314–30323. 31 indexed citations
15.
Stafford, Alan R., et al.. (2009). Long Range Communication between Exosites 1 and 2 Modulates Thrombin Function. Journal of Biological Chemistry. 284(38). 25620–25629. 69 indexed citations
16.
Fredenburgh, James C.. (2002). Antithrombin-Independent Anticoagulation by Hypersulfated Low-Molecular-Weight Heparin. Trends in Cardiovascular Medicine. 12(7). 281–287. 8 indexed citations
17.
Anderson, Julia A. M., James C. Fredenburgh, Alan R. Stafford, et al.. (2001). Hypersulfated Low Molecular Weight Heparin with Reduced Affinity for Antithrombin Acts as an Anticoagulant by Inhibiting Intrinsic Tenase and Prothrombinase. Journal of Biological Chemistry. 276(13). 9755–9761. 21 indexed citations
18.
Liaw, Patricia C., Richard C. Austin, James C. Fredenburgh, Alan R. Stafford, & Jeffrey I. Weitz. (1999). Comparison of Heparin- and Dermatan Sulfate-mediated Catalysis of Thrombin Inactivation by Heparin Cofactor II. Journal of Biological Chemistry. 274(39). 27597–27604. 46 indexed citations
19.
Weitz, Jeffrey I., Edward Young, Marilyn Johnston, et al.. (1999). Vasoflux, a New Anticoagulant With a Novel Mechanism of Action. Circulation. 99(5). 682–689. 30 indexed citations
20.
Stewart, R. J. C., James C. Fredenburgh, & Jeffrey I. Weitz. (1998). Characterization of the Interactions of Plasminogen and Tissue and Vampire Bat Plasminogen Activators with Fibrinogen, Fibrin, and the Complex of d-Dimer Noncovalently Linked to Fragment E. Journal of Biological Chemistry. 273(29). 18292–18299. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026